Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 34.20M | £ 39.40M | £ 19.90M | £ 29.20M | £ 30.30M |
Total Assets | £ 556.70M | £ 523.30M | £ 573.00M | £ 428.60M | £ 414.30M |
Total Debt | £ 22.10M | £ 90.70M | £ 21.60M | £ 97.90M | £ 20.00M |
Net Debt | £ -12.10M | £ 51.30M | £ 1.70M | £ 68.70M | £ -10.30M |
Total Liabilities | £ 243.60M | £ 232.90M | £ 303.70M | £ 219.80M | £ 207.30M |
Stockholders Equity | £ 313.10M | £ 290.40M | £ 269.30M | £ 208.80M | £ 207.00M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |